Showing 3 posts of 3 posts found.


ViiV Healthcare launches Phase III trial for combo HIV treatment

August 16, 2016
Research and Development Dolutegravir, HIV, Tivicay, ViiV Healthcare, epivir, lamivudine, phase III

The Pfizer/GSK spin off ViiV Healthcare has announced the beginning of a Phase III evaluating Tivicay (dolutegravir) and Epivir (lamivudine) …

ViiV HIV drug boost

February 18, 2013
Sales and Marketing Dolutegravir, GSK, HIV, ViiV

ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …

Shionogi and ViiV strike new HIV deal

October 30, 2012
Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV

HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …

Latest content